Skip to main content


Fig. 5 | Clinical Epigenetics

Fig. 5

From: Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas

Fig. 5

DZNeP displays anti-proliferative characteristics. Wound healing assay 0 to 72 h timeline with Row 1: No treatment, Row 2: 5.00 μM DMSO, Row 3: 0.50 μM GSK-343, Row 4: 1.00 μM DZNeP, or Row 5: 5.00 μM EPZ-5687. Images taken at 0 and 72 h. a Wound made same time as treatment with inhibitor. b Wound made 5 days following treatment with inhibitor

Back to article page